Even after being discharged from the hospital, COVID-19 patients face elevated rates of mortality, readmission, and multi-organ dysfunction, according to a new study from the United Kingdom.
According to Epidemiology of Post-COVID Syndrome Following Hospitalization with Coronavirus: A Retrospective Cohort Study, these patients still face a heightened risk of experiencing a major adverse cardiovascular event (MACE).
“With over 3 million people in the UK having tested positive for COVID-19 at the time of writing, and many more who had the disease but never received a test, our findings suggest that the long-term burden of COVID-related morbidity on hospitals and broader healthcare systems is likely to be substantial,’” wrote first author Daniel Ayoubkhani, a principal statistician for the Office for National Statistics in the UK.
Data from more than 47,000 COVID-19 patients treated by the National Health Service (NHS) in England who were discharged by August 31, 2020, was compared with patients who had been hospitalized from January 2019 to September 2020 and did not receive a COVID-19 diagnosis.
With 1 in 10 patients dying after being discharged, it was found that hospital readmissions and patient deaths were both more likely among the group of COVID-19 patients. In addition, the MACE rate was “significantly elevated”—as well as rates of respiratory events and diabetes.
The research has been shared on the medRxiv server as it awaits peer review and can be viewed here.